Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Biphasic Insulins/administration & dosage"'
Publikováno v:
Gao, Y, Luquez, C, Lynggaard, H, Andersen, H & Saboo, B 2014, ' The SimpleMix study with biphasic insulin aspart 30 : a randomized controlled trial investigating patient-driven titration versus investigator-driven titration ', Current Medical Research and Opinion, vol. 30, no. 12, pp. 2483-92 . https://doi.org/10.1185/03007995.2014.960512
OBJECTIVE: The study aimed to confirm the efficacy, through non-inferiority, of patient-driven versus investigator-driven titration of biphasic insulin aspart 30 (BIAsp 30) in terms of glycemic control assessed by HbA1c change.METHODS: SimpleMix was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c284c0cd07f995f5d8fe6a50d578b6f0
https://doi.org/10.1185/03007995.2014.960512
https://doi.org/10.1185/03007995.2014.960512
Autor:
Radhakrishna Sothiratnam, Sultan Linjawi, Paturi Rao, Line Conradsen Hiort, Ramazan Sari, Henning F. Andersen
Publikováno v:
Linjawi, S, Sothiratnam, R, Sari, R, Andersen, H, Hiort, L C & Rao, P 2015, ' The study of once-and twice-daily biphasic insulin aspart 30 (BIAsp 30) with sitagliptin, and twice-daily BIAsp 30 without sitagliptin, in patients with type 2 diabetes uncontrolled on sitagliptin and metformin-The Sit2Mix trial ', Primary care diabetes, vol. 9, no. 5, pp. 370-6 . https://doi.org/10.1016/j.pcd.2014.11.001
AIMS: Investigate efficacy and tolerability of intensifying diabetes treatment with once- or twice-daily biphasic insulin aspart 30 (BIAsp 30) added to sitagliptin, and twice-daily BIAsp 30 without sitagliptin in patients with type 2 diabetes (T2D) i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::283f1e3244ede4ed033650bcc2f4760b